Adam S Grossman sold $1.8M of ADMA stock

Adam S Grossman, President and CEO of Adma Biologics, Inc. (ADMA), sold 147,000 shares of ADMA stock worth $1.8M, per an SEC Form 4 filed Nov 6, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 5, 2026, 1 day before it was made public.

ADMA has moved +0.2% since the trade date, from $13.21 to $13.24 (Nov 12, 2026 close).